Canine Blood Test
Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.
Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.
Testing for NT-proBNP is recommended for all dogs age 6 and older as well as high-risk breeds, the company says.
In an independent clinical study, NT-proBNP was shown to be elevated by more than 10-fold in dogs with heart disease.
NT-proBNP is the preferred biomarker over BNP, the active hormone, as it has higher stability and hence higher values in disease states, according to the company.
For fastest response, visit
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
